130 related articles for article (PubMed ID: 1545125)
21. Soluble interleukin-6 receptor alpha inhibits the cytokine-Induced fractalkine/CX3CL1 expression in human vascular endothelial cells in culture.
Matsumiya T; Imaizumi T; Fujimoto K; Cui X; Shibata T; Tamo W; Kumagai M; Tanji K; Yoshida H; Kimura H; Satoh K
Exp Cell Res; 2001 Sep; 269(1):35-41. PubMed ID: 11525637
[TBL] [Abstract][Full Text] [Related]
22. Soluble interleukin-6 receptor in plasma and in lymphocyte culture supernatants of healthy individuals and patients with systemic lupus erythematosus and rheumatoid arthritis.
Polgár A; Brózik M; Tóth S; Holub M; Hegyi K; Kádár A; Hodinka L; Falus A
Med Sci Monit; 2000; 6(1):13-8. PubMed ID: 11208277
[TBL] [Abstract][Full Text] [Related]
23. Resistance to interleukin 6 in human non-small cell lung carcinoma cell lines: role of receptor components.
Ganapathi MK; Weizer AK; Borsellino S; Bukowski RM; Ganapathi R; Rice T; Casey G; Kawamura K
Cell Growth Differ; 1996 Jul; 7(7):923-9. PubMed ID: 8809410
[TBL] [Abstract][Full Text] [Related]
24. A soluble interleukin 6 receptor isolated from conditioned medium of human breast cancer cells is encoded by a differentially spliced mRNA.
Oh JW; Revel M; Chebath J
Cytokine; 1996 May; 8(5):401-9. PubMed ID: 8726669
[TBL] [Abstract][Full Text] [Related]
25. Retinoic acid-induced growth inhibition of a human myeloma cell line via down-regulation of IL-6 receptors.
Sidell N; Taga T; Hirano T; Kishimoto T; Saxon A
J Immunol; 1991 Jun; 146(11):3809-14. PubMed ID: 2033252
[TBL] [Abstract][Full Text] [Related]
26. Signal through gp130 activated by soluble interleukin (IL)-6 receptor (R) and IL-6 or IL-6R/IL-6 fusion protein enhances ex vivo expansion of human peripheral blood-derived hematopoietic progenitors.
Kimura T; Wang J; Minamiguchi H; Fujiki H; Harada S; Okuda K; Kaneko H; Yokota S; Yasukawa K; Abe T; Sonoda Y
Stem Cells; 2000; 18(6):444-52. PubMed ID: 11072033
[TBL] [Abstract][Full Text] [Related]
27. Soluble interleukin-6 receptors released from T cell or granulocyte/macrophage cell lines and human peripheral blood mononuclear cells are generated through an alternative splicing mechanism.
Horiuchi S; Koyanagi Y; Zhou Y; Miyamoto H; Tanaka Y; Waki M; Matsumoto A; Yamamoto M; Yamamoto N
Eur J Immunol; 1994 Aug; 24(8):1945-8. PubMed ID: 8056053
[TBL] [Abstract][Full Text] [Related]
28. High-level production of alternatively spliced soluble interleukin-6 receptor in serum of patients with adult T-cell leukaemia/HTLV-I-associated myelopathy.
Horiuchi S; Ampofo W; Koyanagi Y; Yamashita A; Waki M; Matsumoto A; Yamamoto M; Yamamoto N
Immunology; 1998 Nov; 95(3):360-9. PubMed ID: 9824498
[TBL] [Abstract][Full Text] [Related]
29. Ki-1 (CD30) antigen is released by Ki-1-positive tumor cells in vitro and in vivo. I. Partial characterization of soluble Ki-1 antigen and detection of the antigen in cell culture supernatants and in serum by an enzyme-linked immunosorbent assay.
Josimovic-Alasevic O; Dürkop H; Schwarting R; Backé E; Stein H; Diamantstein T
Eur J Immunol; 1989 Jan; 19(1):157-62. PubMed ID: 2537734
[TBL] [Abstract][Full Text] [Related]
30. Levels of IL-6 and soluble IL-6 receptor are increased in HIV patients with a history of immune restoration disease after HAART.
Stone SF; Price P; Keane NM; Murray RJ; French MA
HIV Med; 2002 Jan; 3(1):21-7. PubMed ID: 12059947
[TBL] [Abstract][Full Text] [Related]
31. Fluorescence sandwich enzyme-linked immunosorbent assay for detecting human interleukin-2 receptors.
Honda M; Nagao S; Yamamoto N; Tanaka Y; Tozawa H; Tokunaga T
J Immunol Methods; 1988 May; 110(1):129-36. PubMed ID: 2453583
[TBL] [Abstract][Full Text] [Related]
32. Activation of protein kinase C induces de novo synthesis of the soluble interleukin-6 receptor in human B cells.
Körholz D; Nussbaum P; Pafferath B; Mauz-Körholz C; Hempel L; Burdach S
Scand J Immunol; 1994 Nov; 40(5):515-20. PubMed ID: 7973458
[TBL] [Abstract][Full Text] [Related]
33. Protein kinase C activity is rate limiting for shedding of the interleukin-6 receptor.
Müllberg J; Schooltink H; Stoyan T; Heinrich PC; Rose-John S
Biochem Biophys Res Commun; 1992 Dec; 189(2):794-800. PubMed ID: 1335247
[TBL] [Abstract][Full Text] [Related]
34. Monoclonal antibodies to the soluble human IL-6 receptor: affinity purification, ELISA, and inhibition of ligand binding.
Novick D; Engelmann H; Revel M; Leitner O; Rubinstein M
Hybridoma; 1991 Feb; 10(1):137-46. PubMed ID: 2032732
[TBL] [Abstract][Full Text] [Related]
35. Purification and characterization of soluble human IL-6 receptor expressed in CHO cells.
Yasukawa K; Saito T; Fukunaga T; Sekimori Y; Koishihara Y; Fukui H; Ohsugi Y; Matsuda T; Yawata H; Hirano T
J Biochem; 1990 Oct; 108(4):673-6. PubMed ID: 2292596
[TBL] [Abstract][Full Text] [Related]
36. Stimulation of the B9 hybridoma cell line by soluble interleukin-6 receptors.
Diamant M; Hansen MB; Rieneck K; Svenson M; Yasukawa K; Bendtzen K
J Immunol Methods; 1994 Aug; 173(2):229-35. PubMed ID: 8046256
[TBL] [Abstract][Full Text] [Related]
37. Soluble cytokine receptors are present in normal human urine.
Novick D; Engelmann H; Wallach D; Rubinstein M
J Exp Med; 1989 Oct; 170(4):1409-14. PubMed ID: 2529343
[TBL] [Abstract][Full Text] [Related]
38. Clinical effects of soluble interleukin-6 receptor detection on autoimmune rheumatic disease patients.
Chen M; Xu MH; Sun CX; Zhang Z; Du Y
Pak J Med Sci; 2014 Jul; 30(4):759-62. PubMed ID: 25097512
[TBL] [Abstract][Full Text] [Related]
39. A fluorescence sandwich ELISA for detecting soluble and cell-associated human interleukin-2.
Kitamura K; Matsuda K; Ide M; Tokunaga T; Honda M
J Immunol Methods; 1989 Jul; 121(2):281-8. PubMed ID: 2788194
[TBL] [Abstract][Full Text] [Related]
40. New-Generation Heterocyclic Bis-Pentamethinium Salts as Potential Cytostatic Drugs with Dual IL-6R and Mitochondria-Targeting Activity.
Talianová V; Kejík Z; Kaplánek R; Veselá K; Abramenko N; Lacina L; Strnadová K; Dvořánková B; Martásek P; Masařík M; Megová MH; Bušek P; Křížová J; Zdražilová L; Hansíková H; Vlčák E; Filimonenko V; Šedo A; Smetana K; Jakubek M
Pharmaceutics; 2022 Aug; 14(8):. PubMed ID: 36015338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]